A significant advance in cancer research is occurring with the use of mini-antibodies to reactivate dysfunctional p53. This essential tumor inhibitor protein is frequently disabled in many types of tumors, causing https://socialupme.com/story7638060/nanobodies-reactivate-the-p53-protein-the-potential-pathway-for-tumor-treatment